155 related articles for article (PubMed ID: 7727511)
21. The bradykinin B1 receptor antagonist R-954 inhibits Ehrlich tumor growth in rodents.
Fernandes PD; Gomes Nde M; Sirois P
Peptides; 2011 Sep; 32(9):1849-54. PubMed ID: 21835216
[TBL] [Abstract][Full Text] [Related]
22. [Growth-promoting action of L-cysteine and its related compounds on Ehrlich ascites tumor cells in vitro].
Takamura S; Yoshida J; Suzuki S
Nihon Yakurigaku Zasshi; 1991 Dec; 98(6):443-8. PubMed ID: 1783325
[TBL] [Abstract][Full Text] [Related]
23. The toxicity of guanidino compounds in the red blood cell in uremia and the effects of hemodialysis.
Shainkin-Kestenbaum R; Giat Y; Berlyne GM
Nephron; 1982; 31(1):20-3. PubMed ID: 7110471
[TBL] [Abstract][Full Text] [Related]
24. Creatine analogue beta-guanidinopropionic acid alters skeletal muscle AMP deaminase activity.
Tullson PC; Rundell KW; Sabina RL; Terjung RL
Am J Physiol; 1996 Jan; 270(1 Pt 1):C76-85. PubMed ID: 8772432
[TBL] [Abstract][Full Text] [Related]
25. Muscle creatine: in vivo depletion by feeding beta-guanidinopropionic acid.
Shields RP; Whitehair CK
Can J Biochem; 1973 Jul; 51(7):1046-9. PubMed ID: 4725354
[No Abstract] [Full Text] [Related]
26. Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists.
Fecchio D; Russo M; Sirois P; Braquet P; Jancar S
Int J Immunopharmacol; 1990; 12(1):57-65. PubMed ID: 2303318
[TBL] [Abstract][Full Text] [Related]
27. Differential response of adipose tissue gene and protein expressions to 4- and 8-week administration of β-guanidinopropionic acid in mice.
Kato H; Masuda S; Ohira T; Ohira L; Takakura H; Ohira Y; Izawa T
Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29512301
[TBL] [Abstract][Full Text] [Related]
28. Boric acid enhances in vivo Ehrlich ascites carcinoma cell proliferation in Swiss albino mice.
Qureshi S; Al-Shabanah OA; Al-Harbi MM; Al-Bekairi AM; Raza M
Toxicology; 2001 Aug; 165(1):1-11. PubMed ID: 11551427
[TBL] [Abstract][Full Text] [Related]
29. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
[TBL] [Abstract][Full Text] [Related]
30. Nutrition of mouse ascites tumor cells in primary culture. I. Large molecular substances and conditioned media.
Morgan JF
J Natl Cancer Inst; 1970 Mar; 44(3):623-31. PubMed ID: 11515431
[No Abstract] [Full Text] [Related]
31. Cardiac phosphocreatine deficiency induced by GPA during postnatal development in rat.
Pelouch V; Kolár F; Khuchua ZA; Elizarova GV; Milerová M; Ost'ádal B; Saks VA
Mol Cell Biochem; 1996; 163-164():67-76. PubMed ID: 8974041
[TBL] [Abstract][Full Text] [Related]
32. Energetic status and mitochondrial oxidative capacity of rat skeletal muscle in response to creatine analogue ingestion.
Freyssenet D; Berthon P; Barthélémy JC; Busso T; Geyssant A; Denis C
Biochim Biophys Acta; 1995 Mar; 1228(2-3):211-5. PubMed ID: 7893727
[TBL] [Abstract][Full Text] [Related]
33. Contractile economy and aerobic recovery metabolism in skeletal muscle adapted to creatine depletion.
Moerland TS; Kushmerick MJ
Am J Physiol; 1994 Jul; 267(1 Pt 1):C127-37. PubMed ID: 8048475
[TBL] [Abstract][Full Text] [Related]
34. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
Terlikowski S; Sulkowska M; Nowak HF
J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
[TBL] [Abstract][Full Text] [Related]
35. The effects of dietary β-guanidinopropionic acid on growth and muscle fiber development in juvenile red porgy, Pagrus pagrus.
White DP; Baumgarner BL; Watanabe WO; Alam MS; Kinsey ST
Comp Biochem Physiol B Biochem Mol Biol; 2018 Feb; 216():48-58. PubMed ID: 29175483
[TBL] [Abstract][Full Text] [Related]
36. Creatine depletion elicits structural, biochemical, and physiological adaptations in rat costal diaphragm.
Levine S; Tikunov B; Henson D; LaManca J; Sweeney HL
Am J Physiol; 1996 Nov; 271(5 Pt 1):C1480-6. PubMed ID: 8944630
[TBL] [Abstract][Full Text] [Related]
37. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
Terlikowski S; Nowak HF
Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of the cytogenetic and antineoplasmatic effects induced by carboplatin in combination with niacin in human lymphocytes in vitro and in Ehrlich ascites tumor cells in vivo.
Mylonaki-Charalambours E; Mourelatos D; Kotsis A
Chemotherapy; 1998; 44(2):121-8. PubMed ID: 9551243
[TBL] [Abstract][Full Text] [Related]
39. Melatonin effect on the ultrastructure of Ehrlich ascites tumor cells, lifetime and histopathology in Swiss mice.
Batista AP; da Silva TG; Teixeira ÁA; de Medeiros PL; Teixeira VW; Alves LC; dos Santos FA
Life Sci; 2013 Nov; 93(23):882-8. PubMed ID: 24383083
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of cell surface sialoglycoconjugates on wild-type and cultured Ehrlich tumor cells as revealed by quantitative lectin-gold ultrastructural cytochemistry.
Roth J; Li WP; Knibbs RN; MacCallum DK; Song Z; Goldstein IJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11353-7. PubMed ID: 7972063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
